D. van Soolingen

发表

Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements

D. van Soolingen, 2001, Journal of internal medicine.

Genomic Deletions Classify the Beijing/W Strains as a Distinct Genetic Lineage of Mycobacterium tuberculosis

P. Small, D. van Soolingen, S. Gagneux, 2005, Journal of Clinical Microbiology.

Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

D van Soolingen, S Kuijper, L. Schouls, 1997, Journal of clinical microbiology.

Rapid and Simple Approach for Identification of Mycobacterium tuberculosis Complex Isolates by PCR-Based Genomic Deletion Analysis

Max Salfinger, Stewart T. Cole, Dick van Soolingen, 2002, Journal of Clinical Microbiology.

PCR-Based Method To Differentiate the Subspecies of the Mycobacterium tuberculosis Complex on the Basis of Genomic Deletions

Dick van Soolingen, D. van Soolingen, R. Huard, 2003, Journal of Clinical Microbiology.

Origin, Spread and Demography of the Mycobacterium tuberculosis Complex

Falk Hildebrand, Tanja Kubica, Stefan Niemann, 2008, PLoS pathogens.

Identification of a Novel Conjugative Plasmid in Mycobacteria That Requires Both Type IV and Type VII Secretion

A. Pain, H. Spaink, D. van Soolingen, 2014, mBio.

Genomic Polymorphisms for Mycobacterium avium subsp. paratuberculosis Diagnostics

M. Behr, D. van Soolingen, M. Semret, 2005, Journal of Clinical Microbiology.

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

J. Kosterink, D. van Soolingen, J. A. Dijkstra, 2017, Antimicrobial Agents and Chemotherapy.

The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis

J. Farrar, P. Small, D. van Soolingen, 2008, PLoS pathogens.

Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains.

D. van Soolingen, R. van Crevel, I. Parwati, 2010, The Lancet. Infectious diseases.

A Sign of Superspreading in Tuberculosis: Highly Skewed Distribution of Genotypic Cluster Sizes

J. Wallinga, R. Ypma, H. K. Altes, 2013, Epidemiology.

Prevalence and Characterization of Heterogeneous Variable-Number Tandem-Repeat Clusters Comprising Drug-Susceptible and/or Variable Resistant Mycobacterium tuberculosis Complex Isolates in the Netherlands from 2004 to 2016

D. van Soolingen, W. van der Hoek, A. D. de Neeling, 2018, Journal of Clinical Microbiology.

Genomics and Machine Learning for Taxonomy Consensus: The Mycobacterium tuberculosis Complex Paradigm

D. van Soolingen, J. Azé, C. Sola, 2015, PloS one.

Clustering of Tuberculosis Cases Based on Variable-Number Tandem-Repeat Typing in Relation to the Population Structure of Mycobacterium tuberculosis in the Netherlands

D. van Soolingen, M. Borgdorff, P. Supply, 2013, Journal of Clinical Microbiology.

The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?

D. van Soolingen, M. Borgdorff, D. Soolingen, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

American Journal of Epidemiology Practice of Epidemiology Influence of Sampling on Clustering and Associations with Risk Factors in the Molecular Epidemiology of Tuberculosis

D. van Soolingen, M. Borgdorff, S. van den Hof, 2022 .

A Mycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control

D. van Soolingen, J. Richardus, G. de Vries, 2009, BMC infectious diseases.

Tuberculosis outbreaks predicted by characteristics of first patients in a DNA fingerprint cluster.

F. Cobelens, D. van Soolingen, M. Borgdorff, 2008, American journal of respiratory and critical care medicine.

Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis

Nalin Rastogi, Stefan Niemann, Philip Supply, 2006, Journal of Clinical Microbiology.

Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier?

D. van Soolingen, M. Langendam, P. de Haas, 2004, American journal of respiratory and critical care medicine.

Annual Mycobacterium tuberculosis infection risk and interpretation of clustering statistics.

E. Vynnycky, D. van Soolingen, P. Fine, 2003, Emerging infectious diseases.

Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island.

D. van Soolingen, C. Martín, D. Enarson, 2001, American journal of respiratory and critical care medicine.

Transmission of tuberculosis in Havana, Cuba: a molecular epidemiological study by IS6110 restriction fragment length polymorphism typing.

D. van Soolingen, R. Díaz, R. Gómez, 2001, Memorias do Instituto Oswaldo Cruz.

IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran.

D. van Soolingen, M. Doroudchi, A. Ghaderi, 2000, Scandinavian journal of infectious diseases.

Restriction fragment length polymorphism Mycobacterium tuberculosis strains isolated from Greenland during 1992: evidence of tuberculosis transmission between Greenland and Denmark

D. van Soolingen, D. Soolingen, P. de Haas, 1994, Journal of clinical microbiology.

Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains

D van Soolingen, E. Bik, D. van Soolingen, 1991, Infection and immunity.

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis

R. Rebollar-Vega, D. van Soolingen, A. Ochoa‐Leyva, 2020, Frontiers in Immunology.

Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, Nigeria

D. van Soolingen, B. Taiwo, R. Murphy, 2016, Journal of pathogens.

Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages.

D. van Soolingen, C. Maldonado-Bernal, A. Isibasi, 2008, Tuberculosis.

Inventory study of non-tuberculous mycobacteria in the European Union

D. van Soolingen, H. Soini, E. Richter, 2014, BMC Infectious Diseases.

The changing pattern of clinical Mycobacterium avium isolation in the Netherlands.

D. van Soolingen, W. Hoefsloot, M. Boeree, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

F. Drobniewski, G. Tyrrell, J. Keane, 2013, European Respiratory Journal.

The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis

D. van Soolingen, R. Hernández-Pando, L. Amaral, 2010, PloS one.

In vitro activity of thioridazine against mycobacteria.

D. van Soolingen, L. Amaral, M. Boeree, 2009, International journal of antimicrobial agents.

Molecular evidence to support a proposal to reserve the designation Mycobacterium avium subsp. avium for bird-type isolates and 'M. avium subsp. hominissuis' for the human/porcine type of M. avium.

L. Rigouts, D. van Soolingen, F. Portaels, 2002, International journal of systematic and evolutionary microbiology.

GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions

Matthew W. Snyder, J. Shendure, S. Sunyaev, 2019, Nature Communications.

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia

T. Clark, D. van Soolingen, S. Sengstake, 2017, BMC Infectious Diseases.

Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotype.

R. Siezen, D. van Soolingen, N. Smith, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing

D. van Soolingen, J. Alffenaar, S. Srivastava, 2017, Antimicrobial Agents and Chemotherapy.

The Cough Cylinder: a tool to study measures against airborne spread of (myco-) bacteria.

D. van Soolingen, R. de Groot, M. Boeree, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The added effect of thioridazine in the treatment of drug-resistant tuberculosis.

D. van Soolingen, L. Amaral, Z. Udwadia, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data

Julian Parkhill, Stephen D Bentley, Anita C Schürch, 2013, BMC Infectious Diseases.

Role and value of whole genome sequencing in studying tuberculosis transmission.

S. Niemann, D. van Soolingen, M. V. D. Werf, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis cases

S. Niemann, T. Walker, D. van Soolingen, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe

D. van Soolingen, I. Devaux, K. Kremer, 2009, Emerging infectious diseases.

Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to Pyrazinamide

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2011, Journal of Clinical Microbiology.

Validation of the GenoType® MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam

F. Cobelens, D. van Soolingen, R. O'brien, 2010, BMC Infectious Diseases.

Current trends of Mycobacterium tuberculosis molecular epidemiology in Saudi Arabia and associated demographical factors.

D. van Soolingen, B. Varghese, S. Al-Hajoj, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

The Susceptibility of Mycobacterium tuberculosis to Isoniazid and the Arg→Leu Mutation at Codon 463 of katG Are Not Associated

A. van der Ende, D. van Soolingen, H. V. van Doorn, 2001, Journal of Clinical Microbiology.

Surgical treatment of non-tuberculous mycobacterial lung disease: strike in time.

D. van Soolingen, D. Soolingen, M. Boeree, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Assessment of Population Structure and Major Circulating Phylogeographical Clades of Mycobacterium tuberculosis Complex in Bangladesh Suggests a High Prevalence of a Specific Subclade of Ancient M. tuberculosis Genotypes

L. Rigouts, Nalin Rastogi, D. van Soolingen, 2007, Journal of Clinical Microbiology.

Characterization of Mycobacterium africanum subtype I among cows in a dairy farm in Bangladesh using spoligotyping.

D. van Soolingen, K. Zaman, D. Soolingen, 2007, The Southeast Asian journal of tropical medicine and public health.

Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe

Z. Iqbal, J. Gardy, S. Niemann, 2019, Wellcome open research.

Recurrent tuberculosis in the Netherlands – a 24-year follow-up study, 1993 to 2016

D. van Soolingen, S. Verver, C. Erkens, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.

D. van Soolingen, M. Boeree, J. Mouton, 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.

L. Schouls, Sang-Nae Cho, D. van Soolingen, 2004, Journal of microbiological methods.

Increased Transmission of Mycobacterium tuberculosis Beijing Genotype Strains Associated with Resistance to Streptomycin: A Population-Based Study

F. Cobelens, D. van Soolingen, M. Borgdorff, 2012, PloS one.

M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV- infected and non-HIV-infected patients in northern Tanzania

D. van Soolingen, G. Kibiki, C. Sola, 2007, BMC Microbiology.

Epidemiology of Mycobacterium bovis Disease in Humans, the Netherlands, 1993–2007

D. van Soolingen, C. Majoor, M. Boeree, 2011, Emerging infectious diseases.

Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex.

D. van Soolingen, P. Supply, J. van Ingen, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers

F. Cobelens, D. van Soolingen, S. Heysell, 2016, Expert review of anti-infective therapy.

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

S. Kaufmann, D. van Soolingen, S. Baumann, 2005, The Journal of clinical investigation.

Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence

D. van Soolingen, W. Hoefsloot, M. Boeree, 2013, Expert review of anti-infective therapy.

Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia

D. van Soolingen, P. Hsueh, N. Van Hung, 2011, Emerging infectious diseases.

Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans.

D. van Soolingen, D. Soolingen, M. Boeree, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical relevance of Mycobacterium malmoense isolation in the Netherlands

D. van Soolingen, W. Hoefsloot, D. Soolingen, 2009, European Respiratory Journal.

Mycobacterium xenopi Clinical Relevance and Determinants, the Netherlands

D. van Soolingen, W. Hoefsloot, M. Boeree, 2008, Emerging infectious diseases.

Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease

D. van Soolingen, H. Bax, T. Sprong, 2022, Open forum infectious diseases.

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

D. van Soolingen, D. Deshpande, J. Pasipanodya, 2016, Antimicrobial Agents and Chemotherapy.

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

D. van Soolingen, D. Deshpande, J. Pasipanodya, 2016, Antimicrobial Agents and Chemotherapy.

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

D. van Soolingen, D. Deshpande, J. Pasipanodya, 2015, Antimicrobial Agents and Chemotherapy.

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.

D. van Soolingen, J. Mouton, J. van Ingen, 2015, The Journal of antimicrobial chemotherapy.

Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.

D. van Soolingen, J. Mouton, J. van Ingen, 2015, The Journal of antimicrobial chemotherapy.

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin

D. van Soolingen, A. D. de Jong, J. Meletiadis, 2015, Antimicrobial Agents and Chemotherapy.

Utility of rpoB Gene Sequencing for Identification of Nontuberculous Mycobacteria in the Netherlands

D. van Soolingen, J. van Ingen, R. de Zwaan, 2014, Journal of Clinical Microbiology.

Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.

D. van Soolingen, W. Hoefsloot, E. Peters, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence of nontuberculous mycobacteria in COPD patients with exacerbations.

D. van Soolingen, W. Hoefsloot, M. Boeree, 2013, The Journal of infection.

Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.

D. van Soolingen, W. Hoefsloot, M. Boeree, 2013, International journal of antimicrobial agents.

Hypersensitivity pneumonitis caused by Mycobacterium avium subsp. hominissuis in a hot tub, as proven by IS1245 RFLP and rep-PCR typing.

D. van Soolingen, W. Hoefsloot, M. Boeree, 2012, International journal of mycobacteriology.

No human transmission of Mycobacterium malmoense in a perfect storm setting

D. van Soolingen, W. Hoefsloot, M. Boeree, 2012, European Respiratory Journal.

Clinical Manifestations, Diagnosis, and Treatment of Mycobacterium haemophilum Infections

E. Kuijper, D. van Soolingen, J. Prins, 2011, Clinical Microbiology Reviews.

Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species.

J. Crump, D. van Soolingen, R. Selvarangan, 2011, International journal of systematic and evolutionary microbiology.

In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.

D. van Soolingen, M. Boeree, R. Dekhuijzen, 2010, International journal of antimicrobial agents.

Isolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study.

D. van Soolingen, P. Buijtels, H. Verbrugh, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Invasive Disease Caused by Nontuberculous Mycobacteria, Tanzania

J. Crump, J. Bartlett, D. van Soolingen, 2009, Emerging infectious diseases.

Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients.

L. Rigouts, D. van Soolingen, P. de Haas, 2009, International journal of systematic and evolutionary microbiology.

Region of Difference 1 in Nontuberculous Mycobacterium Species Adds a Phylogenetic and Taxonomical Character

D. van Soolingen, M. Boeree, R. Dekhuijzen, 2009, Journal of bacteriology.

Clinical Relevance of Nontuberculous Mycobacteria, Oman

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2009, Emerging infectious diseases.

Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic species.

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2009, International journal of systematic and evolutionary microbiology.

Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay.

D. van Soolingen, M. Boeree, E. Tortoli, 2009, International journal of systematic and evolutionary microbiology.

Nontuberculous Mycobacterium Infection and Tumor Necrosis Factor-α Antagonists

D. van Soolingen, R. Slingerland, J. van Ingen, 2009, Emerging infectious diseases.

Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov.

D. van Soolingen, D. Soolingen, M. Boeree, 2009, International journal of systematic and evolutionary microbiology.

Clinical relevance of Mycobacterium szulgai in The Netherlands.

D. van Soolingen, P. de Haas, M. Boeree, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature.

D. van Soolingen, W. Hoefsloot, M. Boeree, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Clinical relevance of Mycobacterium simiae in pulmonary samples

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2008, European Respiratory Journal.

Clinical Mycobacterium conspicuum Isolation from Two Immunocompetent Patients in The Netherlands

C. Pitz, D. van Soolingen, M. Boeree, 2007, Journal of Clinical Microbiology.

Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection.

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2007, American journal of respiratory and critical care medicine.

The Impact of Nontuberculous Myobacteria on Management of Presumed Pulmonary Tuberculosis

D. van Soolingen, J. Meer, B. Kullberg, 2001, Infection.

Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.

D. van Soolingen, E. Böttger, E. Richter, 2015, The Journal of antimicrobial chemotherapy.

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014

L. Fiebig, D. van Soolingen, R. Duarte, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.

A. Benedetti, D. van Soolingen, D. Menzies, 2017, The Lancet. Infectious diseases.

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.

J. Kosterink, D. van Soolingen, B. Wilffert, 2016, The Journal of antimicrobial chemotherapy.

SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.

D. van Soolingen, G. J. de Knegt, I. Bakker-Woudenberg, 2015, International journal of antimicrobial agents.

Immunological Parameters to Define Infection Progression and Therapy Response in a Well-Defined Tuberculosis Model in Mice

A. van Belkum, D. van Soolingen, M. T. ten Kate, 2009, International journal of immunopathology and pharmacology.

Plasma and Cerebrospinal Fluid Pharmacokinetics of Moxifloxacin in a Patient with Tuberculous Meningitis

D. van Soolingen, G. Luijckx, J. Alffenaar, 2008, Antimicrobial Agents and Chemotherapy.

Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands.

D. van Soolingen, T. S. van der Werf, D. Soolingen, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to ‘bird tuberculosis’

E. Kuijper, D. van Soolingen, D. Soolingen, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

Antimycobacterial Agents Differ with Respect to Their Bacteriostatic versus Bactericidal Activities in Relation to Time of Exposure, Mycobacterial Growth Phase, and Their Use in Combination

D. van Soolingen, H. Verbrugh, I. Bakker-Woudenberg, 2005, Antimicrobial Agents and Chemotherapy.

Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands

D. van Soolingen, W. Hoefsloot, D. Soolingen, 2009, Thorax.

Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity

L. Rigouts, B. D. de Jong, D. van Soolingen, 2018, Memorias do Instituto Oswaldo Cruz.

Validation of Biomarkers for Distinguishing Mycobacterium tuberculosis from Non-Tuberculous Mycobacteria Using Gas Chromatography−Mass Spectrometry and Chemometrics

Ngoc A. Dang, D. van Soolingen, A. Kolk, 2013, PloS one.

Spoligotyping and Mycobacterium tuberculosis

M. Moroni, D. van Soolingen, G. Marchetti, 2005, Emerging infectious diseases.

Rapidly Growing Nontuberculous Mycobacteria Cultured from Home Tap and Shower Water

D. van Soolingen, A. M. de Roda Husman, J. van Ingen, 2010, Applied and Environmental Microbiology.

Misidentification and Diagnostic Delay Caused by a False-Positive Amplified Mycobacterium tuberculosis Direct Test in an Immunocompetent Patient with a Mycobacterium celatum Infection

D. van Soolingen, M. Dessens-Kroon, J. Tjhie, 2001, Journal of Clinical Microbiology.

In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin

J. Kosterink, D. van Soolingen, J. A. Dijkstra, 2018, Antimicrobial Agents and Chemotherapy.

A standardised restriction fragment length polymorphism (RFLP) method for typing Mycobacterium avium isolates links IS901 with virulence for birds.

D. van Soolingen, T. Bull, P. Svastova, 2003, Journal of microbiological methods.

Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis

R. Blumenthal, L. Schouls, D. van Soolingen, 1996, Journal of bacteriology.

Two mycobacterium fortuitum strains isolated from pulmonary tuberculosis patients in Delhi harbour IS6110 homologue.

D. van Soolingen, N. Bhanu, J. V. van Embden, 2004, Diagnostic microbiology and infectious disease.

Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients

J. Kosterink, D. van Soolingen, J. Alffenaar, 2017, Antimicrobial Agents and Chemotherapy.

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.

D. van Soolingen, T. S. van der Werf, D. Soolingen, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

D. van Soolingen, D. Deshpande, J. Pasipanodya, 2016, Antimicrobial Agents and Chemotherapy.

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

John L. Johnson, K. Dooley, V. Furió, 2022, European Respiratory Journal.

Disclosure of Selective Advantages in the “modern” Sublineage of the Mycobacterium tuberculosis Beijing Genotype Family by Quantitative Proteomics*

D. van Soolingen, P. V. van Veelen, P. de Haas, 2014, Molecular & Cellular Proteomics.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

D. van Soolingen, M. T. ten Kate, G. J. de Knegt, 2014, Tuberculosis.

Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.

D. van Soolingen, M. T. ten Kate, G. J. de Knegt, 2013, American journal of respiratory and critical care medicine.

Mycobacterium tuberculosis Beijing Type Mutation Frequency

D. van Soolingen, I. Bakker-Woudenberg, J. D. de Steenwinkel, 2013, Emerging infectious diseases.

Consequences of Noncompliance for Therapy Efficacy and Emergence of Resistance in Murine Tuberculosis Caused by the Beijing Genotype of Mycobacterium tuberculosis

D. van Soolingen, M. D. den Bakker, M. T. ten Kate, 2012, Antimicrobial Agents and Chemotherapy.

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB

D. van Soolingen, M. T. ten Kate, G. J. de Knegt, 2012, Emerging infectious diseases.

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.

D. van Soolingen, H. V. van Doorn, C. Vandenbroucke-Grauls, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.

D. van Soolingen, D. Manissero, D. Soolingen, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Clinical standards for the dosing and management of TB drugs

D. van Soolingen, P. Denti, K. Dheda, 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring.

D. van Soolingen, G. de Vries, N. Kalisvaart, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A Multi-Country Non-Inferiority Cluster Randomized Trial of Frontloaded Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis

A. Ramsay, L. Cuevas, D. van Soolingen, 2011, PLoS medicine.

The microbiological quality of water in fish spas with Garra rufa fish, the Netherlands, October to November 2012.

D. van Soolingen, A. M. de Roda Husman, H. H. van den Berg, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model

P. Roholl, D. van Soolingen, R. Hernández-Pando, 2004, Clinical and experimental immunology.

A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes

D. van Soolingen, R. Hernández-Pando, D. Soolingen, 2003, Clinical and experimental immunology.

Differences in the population of genetics of Mycobacterium tuberculosis between urban migrants and local residents in Beijing, China

D. van Soolingen, Hairong Huang, Li Wang, 2013, Chinese medical journal.

Comparison of Methods Based on Different Molecular Epidemiological Markers for Typing of Mycobacterium tuberculosis Complex Strains: Interlaboratory Study of Discriminatory Power and Reproducibility

R. Frothingham, J. Musser, W. Haas, 1999, Journal of Clinical Microbiology.

The use of microbead-based spoligotyping for Mycobacterium tuberculosis complex to evaluate the quality of the conventional method: Providing guidelines for Quality Assurance when working on membranes

L. Rigouts, Nalin Rastogi, D. van Soolingen, 2011, BMC infectious diseases.

Mapping of IS6110 insertion sites in Mycobacterium bovis isolates in relation to adaptation from the animal to human host.

D. van Soolingen, P. de Haas, K. Kremer, 2008, Veterinary microbiology.

Systematic Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates from Spain

D. van Soolingen, D. Soolingen, C. Martín, 2005, Journal of Clinical Microbiology.

Use of Variable-Number Tandem-Repeat Typing To Differentiate Mycobacterium tuberculosis Beijing Family Isolates from Hong Kong and Comparison with IS6110 Restriction Fragment Length Polymorphism Typing and Spoligotyping

K. Kam, D. van Soolingen, R. Skuce, 2005, Journal of Clinical Microbiology.

Improvement of Differentiation and Interpretability of Spoligotyping for Mycobacterium tuberculosis Complex Isolates by Introduction of New Spacer Oligonucleotides

N. Nagelkerke, L. Schouls, D. van Soolingen, 2002, Journal of Clinical Microbiology.

False-Positive Mycobacterium tuberculosis Cultures in 44 Laboratories in The Netherlands (1993 to 2000): Incidence, Risk Factors, and Consequences

D. van Soolingen, P. de Haas, M. Dessens, 2002, Journal of Clinical Microbiology.

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009

D. van Soolingen, M. Borgdorff, S. van den Hof, 2011, Emerging infectious diseases.

A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.

L. Schouls, D. van Soolingen, A. Cataldi, 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.

D. van Soolingen, H. V. van Doorn, M. Borgdorff, 2000, The Journal of infectious diseases.

Innate Immune Response to Mycobacterium tuberculosis Beijing and Other Genotypes

G. Kaplan, D. van Soolingen, P. Peyron, 2010, PloS one.

A Lipid Profile Typifies the Beijing Strains of Mycobacterium tuberculosis

D. van Soolingen, M. Daffé, P. Constant, 2009, The Journal of Biological Chemistry.

First description of Mycobacterium tuberculosis Beijing genotype in Argentina.

D. van Soolingen, A. Cataldi, K. Kremer, 2005, Revista Argentina de microbiologia.

Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis.

D. van Soolingen, M. Borgdorff, P. de Haas, 2004, Tuberculosis.

Mycobacterium tuberculosis Beijing Genotype, the Netherlands

D. van Soolingen, M. Borgdorff, P. de Haas, 2003, Emerging infectious diseases.

Predominace of a novel Mycobacterium tuberculosis genotype in the Delhi region of India.

R. Pandey, D. van Soolingen, N. Bhanu, 2002, Tuberculosis.

The IS6110 Restriction Fragment Length Polymorphism in Particular Multidrug-Resistant Mycobacterium tuberculosis Strains May Evolve Too Fast for Reliable Use in Outbreak Investigation

D. van Soolingen, A. Cataldi, S. Scipioni, 1999, Journal of Clinical Microbiology.

Genetic profiling of Mycobacterium tuberculosis “modern” Beijing strains from Southwest Colombia

D. van Soolingen, R. Anthony, J. D. de Beer, 2019, bioRxiv.

SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex

Z. Iqbal, S. Niemann, T. Walker, 2019, Emerging infectious diseases.

Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011.

H. K. Altes, D. van Soolingen, D. Soolingen, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates

D. van Soolingen, P. Klatser, S. Sengstake, 2014, BMC Genomics.

Clustering of Beijing genotype Mycobacterium tuberculosis isolates from the Mekong delta in Vietnam on the basis of variable number of tandem repeat versus restriction fragment length polymorphism typing

F. Cobelens, D. van Soolingen, P. de Haas, 2013, BMC Infectious Diseases.

Mixed Tuberculosis Infections in Rural South Vietnam

F. Cobelens, D. van Soolingen, N. Lan, 2012, Journal of Clinical Microbiology.

Multidrug-Resistant Mycobacterium tuberculosis, Southwestern Colombia

D. van Soolingen, B. E. Ferro, L. Forero, 2011, Emerging infectious diseases.

Microevolution of Mycobacterium tuberculosis in a Tuberculosis Patient

D. van Soolingen, P. Supply, S. Al-Hajoj, 2010, Journal of Clinical Microbiology.

Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan

K. Feldmann, D. van Soolingen, D. Soolingen, 2008, European Respiratory Journal.

24-locus MIRU-VNTR genotyping is a useful tool to study the molecular epidemiology of tuberculosis among Warao Amerindians in Venezuela.

D. van Soolingen, K. Kremer, H. Takiff, 2008, Tuberculosis.

Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America.

D. van Soolingen, J. Palomino, P. Suffys, 2008, Memorias do Instituto Oswaldo Cruz.

Drug Susceptibility Testing of Mycobacterium tuberculosis Complex by Use of a High-Throughput, Reproducible, Absolute Concentration Method

D. van Soolingen, K. Kremer, B. van Klingeren, 2007, Journal of Clinical Microbiology.

Tuberculosis Drug Resistance and HIV Infection, the Netherlands

F. Cobelens, D. van Soolingen, N. Kalisvaart, 2007, Emerging infectious diseases.

Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in 2000.

Q. Gao, D. van Soolingen, K. Kremer, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium tuberculosis Beijing Genotype and Risk for Treatment Failure and Relapse, Vietnam

D. van Soolingen, M. Borgdorff, D. Soolingen, 2003, Emerging infectious diseases.

Molecular epidemiological study on transmission of tuberculosis in a hospital for mentally handicapped patients in Havana, Cuba.

D. van Soolingen, R. Díaz, R. Gómez, 2001, The Journal of hospital infection.

Nosocomial transmission of tuberculosis to a nurse demonstrated by means of spoligotyping of a formalin-fixed bronchial biopsy.

D. van Soolingen, A. V. D. van der Zanden, T. Bosje, 2001, The Netherlands journal of medicine.

Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment.

D. van Soolingen, J. Meer, J. V. D. van der Meer, 2001, Emerging infectious diseases.

Usefulness of IS6110-restriction fragment length polymorphism typing of Brazilian strains of Mycobacterium tuberculosis and comparison with an international fingerprint database.

W. Degrave, D. van Soolingen, P. Suffys, 2000, Research in microbiology.

Usefulness of Spoligotyping in Molecular Epidemiology of Mycobacterium bovis-Related Infections in South America

D. van Soolingen, A. Cataldi, Carlos Martín, 1999, Journal of Clinical Microbiology.

A Multidrug-Resistant Tuberculosis Microepidemic Caused by Genetically Closely Related Mycobacterium tuberculosis Strains

D. van Soolingen, K. Kremer, M. Kubín, 1999, Journal of Clinical Microbiology.

Genetic markers for the epidemiology of tuberculosis.

P. Small, D. van Soolingen, J. V. van Embden, 1992, Research in microbiology.

Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype

K. Kam, D. van Soolingen, C. Yip, 2001, Epidemiology and Infection.

Liquid culture for Mycobacterium tuberculosis: proceed, but with caution.

R. Lumb, F. Cobelens, D. van Soolingen, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains

K. Kam, D. van Soolingen, M. Borgdorff, 2009, Emerging infectious diseases.

Mycobacterium tuberculosis lineage 1 genetic diversity in Pará, Brazil, suggests common ancestry with east-African isolates potentially linked to historical slave trade.

Liliana K. Rutaihwa, D. van Soolingen, P. Suffys, 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Characterization of Mycobacterium orygis as M. tuberculosis Complex Subspecies

D. van Soolingen, R. Brosch, M. Boeree, 2012, Emerging infectious diseases.

Retraction Note: Infection of great apes and a zoo keeper with the same Mycobacterium tuberculosis spoligotype

D. van Soolingen, T. S. van der Werf, O. Akkerman, 2014, Medical Microbiology and Immunology.

Predominance of modern Mycobacterium tuberculosis strains and active transmission of Beijing sublineage in Jayapura, Indonesia Papua.

B. Alisjahbana, D. van Soolingen, S. Sengstake, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[Connection between 2 tuberculosis outbreaks demonstrated after 8 years by DNA-fingerprinting of the causative mycobacteria].

D. van Soolingen, K. Kremer, S. Keizer, 1998, Nederlands tijdschrift voor geneeskunde.

Effect of screening of immigrants on tuberculosis transmission.

D. van Soolingen, M. Borgdorff, S. Verver, 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis

H. Frijlink, H. Kerstjens, D. van Soolingen, 2018, European Respiratory Journal.

Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis

J. Kosterink, D. van Soolingen, J. A. Dijkstra, 2016, Antimicrobial Agents and Chemotherapy.

In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis

J. Kosterink, D. van Soolingen, J. Alffenaar, 2014, European Respiratory Journal.

Activity of the efflux pump inhibitor SILA 421 against drug-resistant tuberculosis.

J. Molnár, D. van Soolingen, L. Amaral, 2013, International journal of antimicrobial agents.

Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis.

D. van Soolingen, D. Soolingen, M. Boeree, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge.

D. van Soolingen, D. Soolingen, M. Boeree, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia.

B. Alisjahbana, T. Ottenhoff, D. van Soolingen, 2010, The Journal of infectious diseases.

Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.

D. van Soolingen, G. Luijckx, J. Alffenaar, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[An outbreak of multiresistant tuberculosis from Eastern Europe in the Netherlands].

D. van Soolingen, G. de Vries, R. van Altena, 2005, Nederlands tijdschrift voor geneeskunde.

The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam.

F. Cobelens, D. van Soolingen, M. Borgdorff, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?

D. van Soolingen, J. Grosset, M. Raviglione, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use of IS6110 DNA fingerprinting in tracing man-to-man transmission of Mycobacterium tuberculosis in the Czech Republic.

D. van Soolingen, K. Kremer, M. Kubín, 1996, Central European journal of public health.

Origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands: the truth behind the rates.

N. Nagelkerke, D. van Soolingen, H. Jansen, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Evaluation of SNP-based genotyping to monitor tuberculosis control in a high MDR-TB setting

D. van Soolingen, S. Sengstake, N. Tukvadze, 2016, bioRxiv.

Mycobacterium tuberculosis genotypic drug resistance patterns and clustering in Jayapura, Papua, Indonesia.

B. Alisjahbana, D. van Soolingen, S. Sengstake, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure

D. van Soolingen, A. D. den Hertog, R. Anthony, 2014, Emerging infectious diseases.

Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring.

D. van Soolingen, G. de Vries, N. Kalisvaart, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tuberculosis Acquired Outside of Households, Rural Vietnam

F. Cobelens, D. van Soolingen, M. Borgdorff, 2010, Emerging infectious diseases.

The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam.

F. Cobelens, D. van Soolingen, M. Borgdorff, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Low Induction of Proinflammatory Cytokines Parallels Evolutionary Success of Modern Strains within the Mycobacterium tuberculosis Beijing Genotype

L. Joosten, M. Netea, T. Ottenhoff, 2013, Infection and Immunity.

Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore.

D. van Soolingen, N. Paton, K. Kremer, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Second-line drug resistance in multidrug-resistant tuberculosis cases of various origins in the Netherlands.

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium Tuberculosis Beijing Genotype Induces Differential Cytokine Production by Peripheral Blood Mononuclear Cells of Healthy BCG Vaccinated Individuals

D. van Soolingen, R. Hernández-Pando, I. Estrada-García, 2012, Immunological investigations.

Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes

D. van Soolingen, R. Hernández-Pando, D. Soolingen, 2005, Clinical and experimental immunology.

Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv

D. van Soolingen, T. Ottenhoff, G. J. de Knegt, 2019, Scientific Reports.

Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey

B. Zhao, D. van Soolingen, X. Ou, 2017, PloS one.

Predictive Value of Molecular Drug Resistance Testing of Mycobacterium tuberculosis Isolates in Valle del Cauca, Colombia

D. van Soolingen, Pamela K Garcia, B. E. Ferro, 2013, Journal of Clinical Microbiology.

Comparative Study on Genotypic and Phenotypic Second-Line Drug Resistance Testing of Mycobacterium tuberculosis Complex Isolates

D. van Soolingen, M. Boeree, M. K. Kamst-van Agterveld, 2010, Journal of Clinical Microbiology.

Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.

D. van Soolingen, V. Ritacco, M. Vescovo, 2012, The Journal of antimicrobial chemotherapy.

Mycobacterium tuberculosis and Dual M. tuberculosis/M. bovis Infection as the Cause of Tuberculosis in a Gorilla and a Lioness, Respectively, in Ibadan Zoo, Nigeria

D. van Soolingen, V. Taiwo, Aina O. Adeogun, 2016, Case reports in veterinary medicine.

Comparison of 14 Molecular Assays for Detection of Mycobacterium tuberculosis Complex in Bronchoalveolar Lavage Fluid

H. Kerstjens, D. van Soolingen, J. Rossen, 2013, Journal of Clinical Microbiology.

Characterization of Extensively Drug-Resistant Tuberculosis Cases from Valle del Cauca, Colombia

Nalin Rastogi, D. van Soolingen, C. Moreira, 2012, Journal of Clinical Microbiology.

Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.

S. Mwaigwisya, D. van Soolingen, G. Kibiki, 2011, The Journal of antimicrobial chemotherapy.

Spoligotype Profile of Mycobacterium tuberculosis Complex Strains from HIV-Positive and -Negative Patients in Nigeria: a Comparative Analysis

Nalin Rastogi, D. van Soolingen, S. Cadmus, 2010, Journal of Clinical Microbiology.

Mycobacterium bovis and M. tuberculosis in Goats, Nigeria

D. van Soolingen, H. Adesokan, S. Cadmus, 2009, Emerging infectious diseases.

Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study

D. van Soolingen, W. van der Hoek, R. Anthony, 2018, PloS one.

DNA Sequencing Predicts 1st-Line Tuberculosis Drug Susceptibility Profiles

Daniel J. Wilson, Matthew W. Snyder, J. Shendure, 2018, The New England Journal of Medicine.

Optimization of Standard In-House 24-Locus Variable-Number Tandem-Repeat Typing for Mycobacterium tuberculosis and Its Direct Application to Clinical Material

D. van Soolingen, A. Schürch, T. S. van der Werf, 2014, Journal of Clinical Microbiology.

A model of tuberculosis clustering in low incidence countries reveals more on-going transmission in the United Kingdom than the Netherlands between 2010 and 2015

L. Danon, H. K. Altes, D. van Soolingen, 2019, bioRxiv.

Transposition Rates of Mycobacterium tuberculosis IS6110 Restriction Fragment Length Polymorphism Patterns

P. Eilers, D. van Soolingen, R. Warren, 2004, Journal of Clinical Microbiology.

A Predominant Variable-Number Tandem-Repeat Cluster of Mycobacterium tuberculosis Isolates among Asylum Seekers in the Netherlands and Denmark, Deciphered by Whole-Genome Sequencing

D. van Soolingen, W. van der Hoek, R. Anthony, 2017, Journal of Clinical Microbiology.

Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly

H. Kerstjens, D. van Soolingen, W. Hoefsloot, 2016, European Respiratory Journal.

Clinical Relevance of Rifampicin‐Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis Patients

H. Kerstjens, D. van Soolingen, M. Sturkenboom, 2021, Antimicrobial agents and chemotherapy.

Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis.

D. van Soolingen, L. Amaral, P. V. van Veelen, 2016, Journal of proteome research.

Mycobacterium tuberculosis Beijing genotype, Thailand--reply to Dr. Prodinger.

D. van Soolingen, M. Borgdorff, K. Kremer, 2001, Emerging infectious diseases.

A Novel Advanced Laboratory Diagnosis to Guide Tuberculosis Drug Therapy.

D. van Soolingen, L. Amaral, 2015, Recent patents on anti-infective drug discovery.

Exogenous re-infection as a cause of recurrent tuberculosis in a low-incidence area.

E. Vynnycky, D. van Soolingen, M. Borgdorff, 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Multiple strains of Mycobacterium avium subspecies hominissuis infections associated with aborted fetuses and wasting in pigs

D. van Soolingen, P. de Haas, G. Wellenberg, 2010, Veterinary Record.

Serodiagnosis of Mycobacterium avium infections in pigs.

D. van Soolingen, B. Engel, B. Urlings, 2010, Veterinary Microbiology.

Trimethoprim/sulfamethoxazole susceptibility of Mycobacterium tuberculosis.

D. van Soolingen, J. Alffenaar, T. S. van der Werf, 2013, International journal of antimicrobial agents.

[Findings and ongoing research in the molecular epidemiology of tuberculosis].

D. van Soolingen, K. Kremer, 2009, Kekkaku : [Tuberculosis].

Role of rpsA Gene Sequencing in Diagnosis of Pyrazinamide Resistance

D. van Soolingen, M. Boeree, J. van Ingen, 2013, Journal of Clinical Microbiology.

Characterization of Mycobacterium orygis

D. van Soolingen, R. Brosch, J. van Ingen, 2013, Emerging infectious diseases.

Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

D. van Soolingen, B. Wilffert, A. D. den Hertog, 2016, Expert opinion on drug metabolism & toxicology.

On the road to unravelling the aetiology of non-tuberculous mycobacterial disease.

D. van Soolingen, J. van Ingen, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480

D. van Soolingen, J. Alffenaar, T. S. van der Werf, 2011, Antimicrobial Agents and Chemotherapy.

Population Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent

P. V. van Helden, D. van Soolingen, R. Warren, 2013, PloS one.

Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999-2007.

D. van Soolingen, D. Soolingen, M. Boeree, 2010 .

Human Immunodeficiency Virus and Tuberculosis Coinfection in Children: Challenges in Diagnosis and Treatment

D. van Soolingen, R. de Groot, P. Hermans, 2010, The Pediatric infectious disease journal.

Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!

D. van Soolingen, S. Gillespie, L. Amaral, 2010, International journal of antimicrobial agents.

Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs

D. van Soolingen, J. Alffenaar, T. S. van der Werf, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pound foolish and penny wise-when will dosing of rifampicin be optimised?

D. van Soolingen, J. Alffenaar, R. Anthony, 2018, The Lancet. Respiratory medicine.

Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.

Christian Stolte, Leen Rigouts, Alexander Sloutsky, 2016, American journal of respiratory and critical care medicine.

Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission.

S. le Cessie, D. van Soolingen, B. Koster, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis

D. Soll, D. van Soolingen, P. de Haas, 1991, Journal of clinical microbiology.

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment

D. van Soolingen, M. Cynamon, A. D. den Hertog, 2017, Antimicrobial Agents and Chemotherapy.

Performance of Xpert MTB/RIF Ultra: a matter of dead or alive.

D. van Soolingen, S. Arend, 2018, The Lancet. Infectious diseases.

Tuberculosis after a borderline QuantiFERON result during screening before infliximab

D. van Soolingen, S. Arend, H. Scheper, 2018, European Respiratory Journal.

Positive IS900 In Situ Hybridization Signals as Evidence for Role of Mycobacterium avium subsp. paratuberculosis in Etiology of Crohn's Disease

P. Roholl, D. van Soolingen, A. Herrewegh, 2002, Journal of Clinical Microbiology.

BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations.

D. van Soolingen, A. Buiting, D. P. van Berge Henegouwen, 2001, The Netherlands journal of medicine.

A new evolutionary scenario for the Mycobacterium tuberculosis complex

C. Buchrieser, S. Cole, K. Eiglmeier, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients

J. Kosterink, D. van Soolingen, J. Alffenaar, 2013, European Respiratory Journal.

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

Leen Rigouts, Nalin Rastogi, Wolfgang M Prodinger, 2006, BMC Microbiology.

Rapid Identification of Mycobacteria by Raman Spectroscopy

K. Maquelin, H. Endtz, G. Puppels, 2008, Journal of Clinical Microbiology.

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.

A. van Belkum, D. van Soolingen, M. T. ten Kate, 2010, The Journal of antimicrobial chemotherapy.

European 1: a globally important clonal complex of Mycobacterium bovis.

L. Rigouts, S. Niemann, Sang-Nae Cho, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Two Cases of Mycobacterium microti-Induced Culture-Negative Tuberculosis

D. van Soolingen, P. Sturm, W. Schreurs, 2009, Journal of Clinical Microbiology.

Snapshot of Moving and Expanding Clones of Mycobacterium tuberculosis and Their Global Distribution Assessed by Spoligotyping in an International Study

Nalin Rastogi, Herre Heersma, Igor Mokrousov, 2003, Journal of Clinical Microbiology.

Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction

A H Kolk, E. Bik, D. van Soolingen, 1990, Journal of clinical microbiology.

Application of Sensitive and Specific Molecular Methods To Uncover Global Dissemination of the Major RDRio Sublineage of the Latin American-Mediterranean Mycobacterium tuberculosis Spoligotype Family

Nalin Rastogi, Helmi Mardassi, Paul D van Helden, 2008, Journal of Clinical Microbiology.

A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis.

P. Savelkoul, A. van Belkum, D. van Soolingen, 2004, Journal of microbiological methods.

Mycobacterium microti: More Widespread than Previously Thought

D. van Soolingen, K. Kremer, J. V. van Embden, 1998, Journal of Clinical Microbiology.

Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes

Aldert L. Zomer, M. Netea, D. van Soolingen, 2017, American journal of respiratory and critical care medicine.

Distribution of IS900 restriction fragment length polymorphism types among animal Mycobacterium avium subsp. paratuberculosis isolates from Argentina and Europe.

D. van Soolingen, A. Cataldi, F. Paolicchi, 1999, Veterinary microbiology.

European 2--a clonal complex of Mycobacterium bovis dominant in the Iberian Peninsula.

D. van Soolingen, N. Smith, S. Gordon, 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis

D van Soolingen, D. van Soolingen, J. V. van Embden, 1990, Journal of clinical microbiology.

DNA fingerprinting of Mycobacterium tuberculosis.

D. van Soolingen, D. Soolingen, P. de Haas, 1994, Methods in enzymology.

‘Happy the man, who, studying nature's laws, Thro' known effects can trace the secret cause.’† Do we have enough pieces to solve the pyrazinamide puzzle?

D. van Soolingen, A. D. den Hertog, R. Anthony, 2018, The Journal of antimicrobial chemotherapy.

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.

A. Diacon, M. Hoelscher, D. van Soolingen, 2015, American journal of respiratory and critical care medicine.

Variability and cost implications of three generations of the Roche LightCycler® 480

H. Kerstjens, D. van Soolingen, T. S. van der Werf, 2018, PloS one.

Analysis of genetic polymorphisms affecting the four phospholipase C (plc) genes in Mycobacterium tuberculosis complex clinical isolates.

D. van Soolingen, D. Soolingen, P. de Haas, 2004, Microbiology.

Molecular characteristics of "Mycobacterium canettii" the smooth Mycobacterium tuberculosis bacilli.

Gilles Vergnaud, Christine Pourcel, Michel Fabre, 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Resolving lineage assignation on Mycobacterium tuberculosis clinical isolates classified by spoligotyping with a new high-throughput 3R SNPs based method.

Guislaine Refregier, Jian Zhang, Brigitte Gicquel, 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG

D. van Soolingen, P. de Haas, J. V. van Embden, 1992, Journal of clinical microbiology.

Recurrent tuberculosis due to exogenous reinfection.

D van Soolingen, D. van Soolingen, A S de Boer, 2000, The New England journal of medicine.

Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?

D. van Soolingen, S. Arend, 2011, Clinical Infectious Diseases.

A novel multi SNP based method for the identification of subspecies and associated lineages and sub-lineages of the Mycobacterium tuberculosis complex by whole genome sequencing

Z. Iqbal, S. Niemann, T. Peto, 2017, bioRxiv.

Interactions between helminths and tuberculosis infections: Implications for tuberculosis diagnosis and vaccination in Africa

D. van Soolingen, B. Taiwo, S. Cadmus, 2020, PLoS neglected tropical diseases.

Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians.

D. van Soolingen, R. de Groot, D. Soolingen, 2012, Tuberculosis.

Definition of the Beijing/W Lineage of Mycobacterium tuberculosis on the Basis of Genetic Markers

Stefan Niemann, Troels Lillebaek, Judith R. Glynn, 2004, Journal of Clinical Microbiology.

Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis

J. Kosterink, D. van Soolingen, J. Alffenaar, 2016, European Respiratory Journal.

Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience

J. Kosterink, D. van Soolingen, T. S. van der Werf, 2011, European Respiratory Journal.

Mycobacterium tuberculosis Beijing genotype emerging in Vietnam.

D. van Soolingen, M. Borgdorff, D. Soolingen, 2000, Emerging infectious diseases.

Comparison of PCR with the Routine Procedure for Diagnosis of Tuberculosis in a Population with High Prevalences of Tuberculosis and Human Immunodeficiency Virus

D. van Soolingen, P. Klatser, L. Oskam, 2004, Journal of Clinical Microbiology.

The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives.

D. van Soolingen, X. Ou, Shengfen Wang, 2020, The Journal of infection.

Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with Human Immunodeficiency Virus Infection and Multidrug Resistance in Cases of Tuberculous Meningitis

Guy Thwaites, Dick van Soolingen, J. Farrar, 2006, Journal of Clinical Microbiology.

The association between the NAT2 genetic polymorphisms and risk of DILI during anti‐TB treatment: a systematic review and meta‐analysis

D. van Soolingen, B. Wilffert, J. Alffenaar, 2018, British journal of clinical pharmacology.

DNA Sequencing Predicts 1st-Line Tuberculosis Drug Susceptibility Profiles

Phelim Bradley, Zamin Iqbal, Baoli Zhu, 2018, The New England journal of medicine.

Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation

T. Clark, F. Balloux, K. Holt, 2018, Science Advances.

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

Yang Zhou, Qian Gao, Kris Laukens, 2019, Nature Reviews Microbiology.

Molecular Typing of Mycobacterium tuberculosis by Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Analysis, a More Accurate Method for Identifying Epidemiological Links between Patients with Tuberculosis

E. Willery, C. Locht, D. van Soolingen, 2005, Journal of Clinical Microbiology.

ZIEHL-NEELSEN MICROSCOPY IN THE DIAGNOSIS OF TUBERCULOSIS IN SETTINGS OF HIGH HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE.

D. van Soolingen, P. Waiyaki, S. Mpoke, 2012, East African medical journal.

Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis

D van Soolingen, D. van Soolingen, P. Groenen, 1993, Journal of clinical microbiology.

Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro

D. van Soolingen, P. Klatser, B. Kwok, 2012, PloS one.

Nontuberculous Mycobacteria, Zambia

D. van Soolingen, P. Buijtels, H. Verbrugh, 2009, Emerging infectious diseases.

Worldwide Occurrence of Beijing/W Strains of Mycobacterium tuberculosis: A Systematic Review

D. van Soolingen, P. Bifani, J. Glynn, 2002, Emerging infectious diseases.

Use of Multilocus Variable-Number Tandem-Repeat Analysis for Typing Mycobacterium avium subsp. paratuberculosis

L. Schouls, P. Roholl, D. van Soolingen, 2004, Journal of Clinical Microbiology.

SNP/RD Typing of Mycobacterium tuberculosis Beijing Strains Reveals Local and Worldwide Disseminated Clonal Complexes

R. Siezen, P. V. van Helden, D. van Soolingen, 2011, PloS one.

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.

A. Thomas, D. van Soolingen, E. Agger, 2005, Vaccine.

The effect of age and study duration on the relationship between ‘clustering’ of DNA fingerprint patterns and the proportion of tuberculosis disease attributable to recent transmission

N. Nagelkerke, E. Vynnycky, D. van Soolingen, 2001, Epidemiology and Infection.

A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam.

D. van Soolingen, R. Coutinho, J. V. van Embden, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular epidemiology of tuberculosis in Cambodian children

M. Zwahlen, D. van Soolingen, T. Bodmer, 2014, Epidemiology and Infection.

Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia

J T Douglas, D van Soolingen, D. van Soolingen, 1995, Journal of clinical microbiology.

Tuberculosis Elimination in the Netherlands

Dick van Soolingen, D. van Soolingen, M. Borgdorff, 2005, Emerging infectious diseases.

Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases.

N. Nagelkerke, D. van Soolingen, M. Borgdorff, 2001, American journal of epidemiology.

Characterization of the major formamidopyrimidine–DNA glycosylase homolog in Mycobacterium tuberculosis and its linkage to variable tandem repeats

E. Rødland, D. van Soolingen, P. Brennan, 2009, FEMS immunology and medical microbiology.

A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa.

G. Besra, L. Schouls, D. van Soolingen, 1997, International journal of systematic bacteriology.

Use of DNA Extracts from Ziehl-Neelsen-Stained Slides for Molecular Detection of Rifampin Resistance and Spoligotyping of Mycobacterium tuberculosis

L. Schouls, D. van Soolingen, A. V. D. van der Zanden, 2003, Journal of Clinical Microbiology.

Drug susceptibility testing for optimizing tuberculosis treatment.

D. van Soolingen, S. Simons, 2011, Current pharmaceutical design.

Mycobacterial factors relevant for transmission of tuberculosis.

D. van Soolingen, M. Borgdorff, S. van den Hof, 2011, The Journal of infectious diseases.

Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands.

Dick van Soolingen, D. van Soolingen, M. Boeree, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Donor-derived tuberculosis via orthotopic liver transplantation.

D. van Soolingen, B. van Hoek, S. Arend, 2017, The Netherlands journal of medicine.

Repeatedly negative tuberculin skin tests followed by active tuberculosis in an immunocompetent individual.

D. van Soolingen, T. Ottenhoff, S. Arend, 2001, The Netherlands journal of medicine.

Automated High-Throughput Genotyping for Study of Global Epidemiology of Mycobacterium tuberculosis Based on Mycobacterial Interspersed Repetitive Units

Philip Supply, Dick van Soolingen, C. Locht, 2001, Journal of Clinical Microbiology.

Proteogenomic Analysis of Polymorphisms and Gene Annotation Divergences in Prokaryotes using a Clustered Mass Spectrometry-Friendly Database*

D. van Soolingen, M. Arntzen, B. Thiede, 2010, Molecular & Cellular Proteomics.

Complete Genome Sequence of Mycobacterium phlei Type Strain RIVM601174

A. Pain, D. van Soolingen, W. Bitter, 2012, Journal of bacteriology.

Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis

J. Kosterink, D. van Soolingen, B. Wilffert, 2015, European Respiratory Journal.

ESX‐1‐mediated translocation to the cytosol controls virulence of mycobacteria

P. Peters, D. van Soolingen, R. Brosch, 2012, Cellular microbiology.

Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis

Animut Alebel, Setegn Eshetie, D. van Soolingen, 2018, PloS one.

Mutations in Putative Mutator Genes of Mycobacterium tuberculosis Strains of the W-Beijing Family

D. van Soolingen, P. Bifani, B. Gicquel, 2003, Emerging infectious diseases.

Mechanisms of Phenotypic Rifampicin Tolerance in Mycobacterium tuberculosis Beijing Genotype Strain B0/W148 Revealed by Proteomics.

D. van Soolingen, P. V. van Veelen, A. D. de Ru, 2016, Journal of proteome research.

Divergent effect of bacillus Calmette–Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research

A. Thomas, D. van Soolingen, S. Florquin, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature.

N Rastogi, C Sola, J. T. Crawford, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Global Distribution of Mycobacterium tuberculosis Spoligotypes

Nalin Rastogi, Herre Heersma, Igor Mokrousov, 2002, Emerging infectious diseases.

UvA-DARE ( Digital Academic Repository ) Nosocomial Mycobacterium bovis-bacille Calmette-Guerin infections due to contamination of chemotherapeutics : Case finding and route of transmission

D. van Soolingen, H. Verbrugh, A. Vulto, 2003 .

ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii.

L. Rigouts, D. van Soolingen, P. Andersen, 2005, The Journal of infectious diseases.

Transmission of tuberculosis within family-households.

D. van Soolingen, K. Kremer, T. Jagielski, 2012, The Journal of infection.

Family outbreaks of tuberculosis in South Moravia, a low incidence area of the Czech Republic.

D. van Soolingen, K. Kremer, M. Kubín, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Transmission between HIV‐infected patients of multidrug‐resistant tuberculosis caused by Mycobacterium bovis

F. Baquero, D. van Soolingen, J. Blázquez, 1997, AIDS.

Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus.

E. Kuijper, C. Schultsz, D. van Soolingen, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism.

D van Soolingen, R Diaz, D. van Soolingen, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania

J. Bennedsen, D. van Soolingen, M. Mwasekaga, 1995, Journal of clinical microbiology.

DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing.

D. van Soolingen, A. Schürch, 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Novel Genetic Polymorphisms That Further Delineate the Phylogeny of the Mycobacterium tuberculosis Complex

Michel Fabre, Dick van Soolingen, D. van Soolingen, 2006, Journal of bacteriology.

Utility of Mycobacterial Interspersed Repetitive Unit Typing for Differentiating Multidrug-Resistant Mycobacterium tuberculosis Isolates of the Beijing Family

K. Kam, D. van Soolingen, C. Yip, 2005, Journal of Clinical Microbiology.

[Transmission of sensitive and resistant strains of Mycobacterium tuberculosis in The Netherlands, 1993-1995, studied by means of DNA fingerprinting].

D. van Soolingen, P. de Haas, J. V. van Embden, 1996, Nederlands tijdschrift voor geneeskunde.

Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting.

N. Nagelkerke, D. van Soolingen, M. Borgdorff, 1998, American journal of epidemiology.

Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.

D van Soolingen, J. Musser, D. van Soolingen, 1996, The Journal of infectious diseases.

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

D. van Soolingen, M. Borgdorff, D. Soolingen, 1999, The Journal of infectious diseases.

Estimation of serial interval and incubation period of tuberculosis using DNA fingerprinting.

D van Soolingen, N. Nagelkerke, W. Devillé, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[Osteomyelitis as a complication following BCG vaccination].

D. van Soolingen, A. Ruitenberg, M. Withagen, 1995, Nederlands tijdschrift voor geneeskunde.

Molecular epidemiology of tuberculosis in Denmark in 1992

D van Soolingen, D. van Soolingen, P. de Haas, 1995, Journal of clinical microbiology.

Bead Array Direct rRNA Capture Assay (rCapA) for Amplification Free Speciation of Mycobacterium Cultures

D. van Soolingen, P. Klatser, R. Anthony, 2012, PloS one.

Practical biosafety in the tuberculosis laboratory: containment at the source is what truly counts.

R. Lumb, D. van Soolingen, R. Anthony, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use of RODAC plates to measure containment of Mycobacterium tuberculosis in a Class IIB biosafety cabinet during routine operations

L. Rigouts, E. Nduwamahoro, B. D. de Jong, 2016, International journal of mycobacteriology.

Application of modern microbiological diagnostic methods for tuberculosis in Macha, Zambia.

D. van Soolingen, J. Nouwen, J. V. van Dijk, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Novel Multiplex Real-Time PCR Diagnostic Assay for Identification and Differentiation of Mycobacterium tuberculosis, Mycobacterium canettii, and Mycobacterium tuberculosis Complex Strains

J. O’Grady, D. van Soolingen, Kate Reddington, 2010, Journal of Clinical Microbiology.

TB diagnosis in non-human primates: comparison of two interferon-gamma assays and the skin test for identification of Mycobacterium tuberculosis infection.

A. Thomas, D. van Soolingen, P. Andersen, 2004, Veterinary immunology and immunopathology.

African 2, a Clonal Complex of Mycobacterium bovis Epidemiologically Important in East Africa

L. Rigouts, P. V. van Helden, D. van Soolingen, 2010, Journal of bacteriology.

Bacille Calmette-Guérin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG.

D. van Soolingen, Y. Smulders, H. van Deutekom, 1996, Clinical Infectious Diseases.

Mycobacterium avium in a shower linked to pulmonary disease

D. van Soolingen, M. Iseman, D. Soolingen, 2008 .

Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients.

D. van Soolingen, M. Boeree, R. Dekhuijzen, 2009, The Journal of infection.

Diagnosis and treatment of lung infection with nontuberculous mycobacteria

Sandra M Arend, Tom H M Ottenhoff, Dick van Soolingen, 2009, Current opinion in pulmonary medicine.

The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach.

Ronald B Geskus, Dick van Soolingen, R. Geskus, 2011, International journal of epidemiology.

A Novel Multiplex Real-Time PCR for the Identification of Mycobacteria Associated with Zoonotic Tuberculosis

J. O’Grady, S. Niemann, D. van Soolingen, 2011, PloS one.

Progress towards tuberculosis elimination: secular trend, immigration and transmission

D. van Soolingen, M. Borgdorff, D. Soolingen, 2010, European Respiratory Journal.

Emerging drugs and alternative possibilities in the treatment of tuberculosis

D. van Soolingen, M. Sturkenboom, S. Ghimire, 2016, Expert opinion on emerging drugs.

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Daniel J. Wilson, Youwen Qin, M. Inouye, 2022, The Lancet. Microbe.

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

P. Ashton, J. Gardy, L. Rigouts, 2019, Nature Reviews Microbiology.

Whole genome sequencing as the ultimate tool to diagnose tuberculosis

D. van Soolingen, R. Jajou, A. Mulder, 2016, International Journal of Mycobacteriology.

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area

D. van Soolingen, R. Anthony, D. Cirillo, 2022, Microbiology spectrum.

WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.

D. van Soolingen, R. Anthony, A. D. de Neeling, 2019, The Journal of antimicrobial chemotherapy.

Epidemiology of Isoniazid Resistance Mutations and Their Effect on Tuberculosis Treatment Outcomes

Dick van Soolingen, F. Cobelens, D. van Soolingen, 2013, Antimicrobial Agents and Chemotherapy.

Genetic profiling of Mycobacterium tuberculosis revealed “modern” Beijing strains linked to MDR-TB from Southwestern Colombia

D. van Soolingen, R. Anthony, J. D. de Beer, 2020, PloS one.

Disease dynamics in cyclic populations of field voles (Microtus agrestis): cowpox virus and vole tuberculosis (Mycobacterium microti)

M. Begon, D. van Soolingen, R. Cavanagh, 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.

Host-pathogen co-adaptation shapes susceptibility to infection with Mycobacterium tuberculosis

S. Niemann, P. Kouw, D. van Soolingen, 2022, medRxiv.

Genomic characterization of Mycobacterium tuberculosis lineage 7 and a proposed name: ‘Aethiops vetus’

D. van Soolingen, R. Brosch, S. Yimer, 2016, Microbial genomics.

Isolation of the Genome Sequence Strain Mycobacterium avium 104 from Multiple Patients over a 17-Year Period

M. Behr, D. van Soolingen, K. Horan, 2006, Journal of Clinical Microbiology.

Parallel reaction monitoring of clinical Mycobacterium tuberculosis lineages reveals pre-existent markers of rifampicin tolerance in the emerging Beijing lineage.

D. van Soolingen, P. V. van Veelen, A. D. de Ru, 2017, Journal of proteomics.

Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.

D. van Soolingen, E. Lemma, D. Demissie, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Pathological and immunological effects of respirable coal fly ash in male Wistar rats.

H. van Loveren, D. van Soolingen, L. van Bree, 1999, Inhalation toxicology.

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis

J. Kosterink, D. van Soolingen, J. Alffenaar, 2012, European Respiratory Journal.

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.

L. Rigouts, D. van Soolingen, M. Boeree, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?

D. van Soolingen, C. Daley, M. Iseman, 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum.

D. van Soolingen, R. Warren, N. Beyers, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe

D. van Soolingen, D. Hillemann, D. Cirillo, 2020, European Respiratory Journal.

Extensive Genomic Polymorphism within Mycobacterium avium

M. Behr, D. van Soolingen, S. Mostowy, 2004, Journal of bacteriology.

Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

J. Kosterink, D. van Soolingen, Simon Tiberi, 2017, European Respiratory Journal.

GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10,000 Genomes

Daniel J. Wilson, Z. Iqbal, D. Clifton, 2019, bioRxiv.

Ecotypes of the Mycobacterium tuberculosis complex.

D. van Soolingen, N. Smith, John M Smith, 2006, Journal of theoretical biology.

Molecular Characteristics and Global Spread of Mycobacterium tuberculosis with a Western Cape F11 Genotype

Robin Warren, Thomas C Victor, Petra E W de Haas, 2004, Journal of Clinical Microbiology.

Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates

D. van Soolingen, P. Klatser, S. Sengstake, 2014, BMC Genomics.

Fatal Mycobacterium bovis bacille Calmette-Guérin infection caused by contamination of chemotherapeutic agents and not by endogenous reactivation: correction of a previous conclusion.

D. van Soolingen, M. Vos, P. de Haas, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-Resolution Typing by Integration of Genome Sequencing Data in a Large Tuberculosis Cluster

R. Siezen, D. van Soolingen, A. Schürch, 2010, Journal of Clinical Microbiology.

Discriminatory Power and Reproducibility of Novel DNA Typing Methods for Mycobacterium tuberculosis Complex Strains

Philip Supply, Catherine Arnold, Stefan Panaiotov, 2005, Journal of Clinical Microbiology.

Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates.

D van Soolingen, N. Nagelkerke, D. van Soolingen, 1999, The Journal of infectious diseases.

Diagnosis of Mycobacterium microtiInfections among Humans by Using Novel Genetic Markers

D. van Soolingen, F. Portaels, N. Foudraine, 1998, Journal of Clinical Microbiology.

Disseminated Mycobacterium tuberculosis infection of the upper respiratory tract diagnosed by spoligotyping.

D. van Soolingen, A. V. D. van der Zanden, R. Rammeloo, 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017–2019: an ECDC pilot study

S. Niemann, D. van Soolingen, R. Anthony, 2020, European Respiratory Journal.

The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale.

R. Siezen, D. van Soolingen, N. Smith, 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.

T. Ottenhoff, D. van Soolingen, K. V. van Meijgaarden, 2002, The Journal of infectious diseases.

Antituberculosis drug resistance in the south of Vietnam: prevalence and trends.

F. Cobelens, D. van Soolingen, M. Borgdorff, 2006, The Journal of infectious diseases.

Prevalence of Mycobacterium avium in Slaughter Pigs in The Netherlands and Comparison of IS1245Restriction Fragment Length Polymorphism Patterns of Porcine and Human Isolates

F. V. van Zijderveld, D. van Soolingen, P. de Haas, 1999, Journal of Clinical Microbiology.

Characterization of Ancestral Mycobacterium tuberculosis by Multiple Genetic Markers and Proposal of Genotyping Strategy

Sindhu Ravindran, Philip Supply, Richard Bellamy, 2004, Journal of Clinical Microbiology.

Transmission of tuberculosis between people of different ages in The Netherlands: an analysis using DNA fingerprinting.

N. Nagelkerke, D. van Soolingen, M. Borgdorff, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Pulmonary tuberculosis due to Mycobacterium microti in a human immunodeficiency virus-infected patient.

P. Reiss, D. van Soolingen, N. Foudraine, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

IS1245 Restriction Fragment Length Polymorphism Typing of Mycobacterium avium Isolates: Proposal for Standardization

Nalin Rastogi, D. van Soolingen, T. Bodmer, 1998, Journal of Clinical Microbiology.

Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa.

R. Auckenthaler, D. van Soolingen, G. Pfyffer, 1998, Emerging infectious diseases.

Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting.

D. van Soolingen, P. de Haas, W. Hendriks, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use of IS901 and IS1245 in RFLP typing of Mycobacterium avium complex: relatedness among serovar reference strains, human and animal isolates.

D. van Soolingen, P. de Haas, K. Kremer, 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[Pigs possibly are a source of Mycobacterium avium infections in man].

D. van Soolingen, R. Komijn, D. Bakker, 1998, Tijdschrift voor diergeneeskunde.

Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci.

F. Mooi, M. Steiert, D. van Soolingen, 1996, The Journal of antimicrobial chemotherapy.

Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology.

D. van Soolingen, F. Portaels, D. Soolingen, 1995, The Journal of infectious diseases.

Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis

D. van Soolingen, D. Soolingen, P. de Haas, 1994, Journal of clinical microbiology.

Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae

D. van Soolingen, J. V. van Embden, P. Hermans, 1992, Journal of bacteriology.

Targeted Hybridization of IS6110 Fingerprints Identifies the W-Beijing Mycobacterium tuberculosis Strains among Clinical Isolates

D. van Soolingen, P. Bifani, B. Kreiswirth, 2005, Journal of Clinical Microbiology.

Characterisation of Mycobacterium tuberculosis isolates lacking IS6110 in Viet Nam.

F. Cobelens, D. van Soolingen, C. Sola, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Dealing with variation in molecular typing of Mycobacterium tuberculosis: low-intensity bands and other challenges.

D. van Soolingen, R. Arbeit, 2001, Journal of medical microbiology.

Comparative Study of IS6110 Restriction Fragment Length Polymorphism and Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Isolates in the Netherlands, Based on a 5-Year Nationwide Survey

D. van Soolingen, G. de Vries, K. Kremer, 2013, Journal of Clinical Microbiology.

First Worldwide Proficiency Study on Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Complex Strains

Philip Supply, Dick van Soolingen, D. van Soolingen, 2011, Journal of Clinical Microbiology.

Genetic Heterogeneity in Mycobacterium tuberculosisIsolates Reflected in IS6110 Restriction Fragment Length Polymorphism Patterns as Low-Intensity Bands

D. van Soolingen, M. Borgdorff, P. de Haas, 2000, Journal of Clinical Microbiology.

Mycobacterium tuberculosis Genotype and Case Notification Rates, Rural Vietnam, 2003–2006

F. Cobelens, D. van Soolingen, M. Borgdorff, 2009, Emerging infectious diseases.

Characterization of the Manila Family of Mycobacterium tuberculosis

James M. Musser, James T. Douglas, J. Musser, 2003, Journal of Clinical Microbiology.

Combined Species Identification, Genotyping, and Drug Resistance Detection of Mycobacterium tuberculosis Cultures by MLPA on a Bead-Based Array

F. Cobelens, D. van Soolingen, P. Klatser, 2012, PloS one.

Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?

J. Wallinga, H. K. Altes, D. van Soolingen, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Restriction fragment length polymorphism typing of mycobacteria.

D. van Soolingen, D. Soolingen, P. de Haas, 2001, Methods in molecular medicine.

Use of DNA fingerprinting in international source case finding during a large outbreak of tuberculosis in The Netherlands.

D. van Soolingen, J. Veen, A. Drost, 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A new nomenclature for the livestock-associated Mycobacterium tuberculosis complex based on phylogenomics

D. van Soolingen, D. Brites, S. Gagneux, 2021, Open research Europe.

Epidemiology of tuberculosis by DNA fingerprinting.

D. van Soolingen, P. Hermans, 1995, The European respiratory journal. Supplement.

The impact of diabetes mellitus on pulmonary TB.

D. van Soolingen, R. Anthony, Y. Zhang, 2022, Public Health Action.

Complete Genome Sequence of Mycobacterium vaccae Type Strain ATCC 25954

A. Pain, D. van Soolingen, W. Bitter, 2012, Journal of bacteriology.

Microarray analysis of Mycobacterium microti reveals deletion of genes encoding PE-PPE proteins and ESAT-6 family antigens.

J. Hinds, D. van Soolingen, S. Gordon, 2004, Tuberculosis.

Fluorescence microscopy for tuberculosis diagnosis.

F. Cobelens, D. van Soolingen, R. Anthony, 2007, The Lancet. Infectious diseases.

A Novel Approach - The Propensity to Propagate (PTP) Method for Controlling for Host Factors in Studying the Transmission of Mycobacterium Tuberculosis

Dick van Soolingen, D. van Soolingen, M. Murray, 2014, PloS one.

The appearance of sugI mixed loci in three individuals during treatment for MDR-TB, supports the involvement of sugI in Mycobacterium tuberculosis d-cycloserine resistance in vivo

F. van Leth, D. van Soolingen, M. Sturkenboom, 2023, bioRxiv.

Correction: Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study

D. van Soolingen, W. van der Hoek, R. Anthony, 2018, PLoS ONE.

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

J. Bayona, D. van Soolingen, K. Dheda, 2010, The Lancet.

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

J. Kosterink, D. van Soolingen, J. Alffenaar, 2010, Clinical pharmacokinetics.

M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV- infected and non-HIV-infected patients in northern Tanzania

D. van Soolingen, G. Kibiki, C. Sola, 2007, BMC microbiology.

Membrane Filtration Is Suitable for Reliable Elimination of Mycobacterium tuberculosis from Saliva for Therapeutic Drug Monitoring

D. van Soolingen, J. Alffenaar, O. Akkerman, 2017, Journal of Clinical Microbiology.

The problem of resistance in Mycobacterium tuberculosis may be underestimated in Africa

D. van Soolingen, B. Taiwo, O. Falodun, 2018, International journal of mycobacteriology.

Isolation of mycobacteria other than Mycobacterium avium from porcine lymph nodes.

Dick van Soolingen, D. van Soolingen, M. Boeree, 2010, Veterinary microbiology.

To Be or Not to Be a Pseudogene: A Molecular Epidemiological Approach to the mclx Genes and Its Impact in Tuberculosis

D. van Soolingen, M. V. Mendes, M. Correia-Neves, 2015, PloS one.

Occurrence and Nature of Double Alleles in Variable-Number Tandem-Repeat Patterns of More than 8,000 Mycobacterium tuberculosis Complex Isolates in The Netherlands

D. van Soolingen, W. van der Hoek, R. Anthony, 2017, Journal of Clinical Microbiology.

XDR tuberculosis.

D. van Soolingen, C. Daley, M. Iseman, 2011, The Lancet. Infectious diseases.

SeekTB, a Two-Stage Multiplex Real-Time-PCR-Based Method for Differentiation of the Mycobacterium tuberculosis Complex

J. O’Grady, S. Niemann, Alimuddin Zumla, 2012, Journal of Clinical Microbiology.

Transmission and Progression to Disease of Mycobacterium tuberculosis Phylogenetic Lineages in The Netherlands

D. van Soolingen, M. Borgdorff, H. Nebenzahl-Guimaraes, 2015, Journal of Clinical Microbiology.

Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains.

D. van Soolingen, R. van Crevel, I. Parwati, 2010, The Lancet. Infectious diseases.

Mycobacterium tuberculosis Population Structures Differ Significantly on Two Indonesian Islands

B. Alisjahbana, D. van Soolingen, R. van Crevel, 2008, Journal of Clinical Microbiology.

In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis

J. Kosterink, D. van Soolingen, J. Alffenaar, 2014, European Respiratory Journal.

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients

J. Kosterink, D. van Soolingen, J. Alffenaar, 2013, European Respiratory Journal.

Otomastoiditis Caused by Mycobacterium abscessus, the Netherlands

D. van Soolingen, M. Boeree, R. Dekhuijzen, 2010, Emerging infectious diseases.

Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to Pyrazinamide

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2011, Journal of Clinical Microbiology.

The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach.

R. Geskus, D. van Soolingen, M. Borgdorff, 2011, International journal of epidemiology.

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014

L. Fiebig, D. van Soolingen, R. Duarte, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America.

D. van Soolingen, J. Palomino, P. Suffys, 2008, Memorias do Instituto Oswaldo Cruz.

High-Resolution Typing by Integration of Genome Sequencing Data in a Large Tuberculosis Cluster

R. Siezen, D. van Soolingen, A. Schürch, 2010, Journal of Clinical Microbiology.

Clustering of Tuberculosis Cases Based on Variable-Number Tandem-Repeat Typing in Relation to the Population Structure of Mycobacterium tuberculosis in the Netherlands

D. van Soolingen, M. Borgdorff, P. Supply, 2013, Journal of Clinical Microbiology.

Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans.

J. Hinds, D. van Soolingen, K. Kremer, 2004, Microbiology.

Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological marker.

D. van Soolingen, D. Soolingen, 2014, The Lancet. Respiratory medicine.

Genetic Mutations Occur Gradually in In Vivo Populations of Mycobacterium tuberculosis Bacteria

D. van Soolingen, M. Borgdorff, A. D. de Boer, 2001, Journal of Clinical Microbiology.

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure

D. van Soolingen, A. D. den Hertog, R. Anthony, 2014, Emerging infectious diseases.

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

L. Rigouts, S. Niemann, Nalin Rastogi, 2006, BMC Microbiology.

Mixed Tuberculosis Infections in Rural South Vietnam

F. Cobelens, D. van Soolingen, N. Lan, 2012, Journal of Clinical Microbiology.

Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia.

A. van Belkum, D. van Soolingen, P. Buijtels, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Mycobacterium avium in a shower linked to pulmonary disease.

D. van Soolingen, M. Iseman, P. de Haas, 2008, Journal of water and health.

Predictive Value of Molecular Drug Resistance Testing of Mycobacterium tuberculosis Isolates in Valle del Cauca, Colombia

D. van Soolingen, Pamela K Garcia, B. E. Ferro, 2013, Journal of Clinical Microbiology.

Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011.

D. van Soolingen, M. V. D. Werf, D. Soolingen, 2014 .

Low Induction of Proinflammatory Cytokines Parallels Evolutionary Success of Modern Strains within the Mycobacterium tuberculosis Beijing Genotype

L. Joosten, M. Netea, T. Ottenhoff, 2013, Infection and Immunity.

Investigation on Mycobacterium tuberculosis Diversity in China and the Origin of the Beijing Clade

D. van Soolingen, Y. Hauck, G. Vergnaud, 2011, PloS one.

Fast Ligation-Mediated PCR, a Fast and Reliable Method for IS6110-Based Typing of Mycobacterium tuberculosis Complex

W. Haas, B. Amthor, D. van Soolingen, 2005, Journal of Clinical Microbiology.

Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.

I. Marinou, D. van Soolingen, G. Samonis, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements

D. van Soolingen, D. Soolingen, D. Van Soolingen, 2001, Journal of internal medicine.

The respiratory microbiota: new insights into pulmonary tuberculosis

Setegn Eshetie, D. van Soolingen, 2019, BMC Infectious Diseases.

Characteristic SNPs defining the major multidrug-resistant Mycobacterium tuberculosis clusters identified by EuSeqMyTB to support routine surveillance, EU/EEA, 2017 to 2019

D. van Soolingen, E. Tagliani, M. J. van der Werf, 2024, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.

D. van Soolingen, E. Böttger, E. Richter, 2015, The Journal of antimicrobial chemotherapy.

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis

J. Kosterink, D. van Soolingen, J. Alffenaar, 2012, European Respiratory Journal.

Exposure of Dentists to Mycobacterium tuberculosis, Ibadan, Nigeria

D. van Soolingen, B. Taiwo, S. Cadmus, 2010, Emerging infectious diseases.

Novel Genetic Polymorphisms That Further Delineate the Phylogeny of the Mycobacterium tuberculosis Complex

D. van Soolingen, J. Ho, P. de Haas, 2006, Journal of bacteriology.

American Journal of Epidemiology Practice of Epidemiology Influence of Sampling on Clustering and Associations with Risk Factors in the Molecular Epidemiology of Tuberculosis

D. van Soolingen, M. Borgdorff, S. van den Hof, 2022 .

Utility of rpoB Gene Sequencing for Identification of Nontuberculous Mycobacteria in the Netherlands

D. van Soolingen, D. Soolingen, J. Ingen, 2014, Journal of Clinical Microbiology.

Mycobacterium riyadhense overlooked: we can only find what we are looking for.

D. van Soolingen, B. Varghese, S. Al-Hajoj, 2013, Journal of infection in developing countries.

Region of Difference 1 in Nontuberculous Mycobacterium Species Adds a Phylogenetic and Taxonomical Character

D. van Soolingen, M. Boeree, R. Dekhuijzen, 2009, Journal of bacteriology.

Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.

D. van Soolingen, M. Boeree, P. Dekhuijzen, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.